DK1315518T3 - Vaccine mod mikrobielle patogener - Google Patents

Vaccine mod mikrobielle patogener

Info

Publication number: DK1315518T3
Authority: DK; Denmark
Prior art keywords: heat shock; vaccine; present; shock protein; repressor
Prior art date: 2000-09-04

Application number

DK01963230.6T

Other languages

English (en)

Inventor

Camilo Anthony Leo Selwyn Colaco

Original Assignee

Immunobiology Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-04

Filing date

2001-09-04

Publication date

2010-04-19

2001-09-04 Application filed by Immunobiology Ltd filed Critical Immunobiology Ltd

2010-04-19 Application granted granted Critical

2010-04-19 Publication of DK1315518T3 publication Critical patent/DK1315518T3/da

Links

244000000010 microbial pathogen Species 0.000 title abstract 5
229960005486 vaccine Drugs 0.000 title abstract 5
108010004889 Heat-Shock Proteins Proteins 0.000 abstract 4
102000002812 Heat-Shock Proteins Human genes 0.000 abstract 3
230000001939 inductive effect Effects 0.000 abstract 3
230000035882 stress Effects 0.000 abstract 2
241000894006 Bacteria Species 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
238000012217 deletion Methods 0.000 abstract 1
230000037430 deletion Effects 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
230000008642 heat stress Effects 0.000 abstract 1
230000036039 immunity Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
230000008723 osmotic stress Effects 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
239000013598 vector Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6043—Heat shock proteins

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Microbiology (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Mycology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK01963230.6T 2000-09-04 2001-09-04 Vaccine mod mikrobielle patogener DK1315518T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0021757.0A GB0021757D0 (en)	2000-09-04	2000-09-04	Vaccine against microbial pathogens
PCT/GB2001/003964 WO2002020045A2 (en)	2000-09-04	2001-09-04	Vaccine against microbial pathogens

Publications (1)

Publication Number	Publication Date
DK1315518T3 true DK1315518T3 (da)	2010-04-19

Family

ID=9898866

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01963230.6T DK1315518T3 (da)	2000-09-04	2001-09-04	Vaccine mod mikrobielle patogener

Country Status (15)

Country	Link
US (1)	US20050232946A1 (da)
EP (1)	EP1315518B1 (da)
JP (1)	JP2004508339A (da)
CN (1)	CN1452495A (da)
AT (1)	ATE450270T1 (da)
AU (1)	AU2001284261A1 (da)
CA (1)	CA2421229A1 (da)
DE (1)	DE60140681D1 (da)
DK (1)	DK1315518T3 (da)
ES (1)	ES2337653T3 (da)
GB (1)	GB0021757D0 (da)
IL (1)	IL154727A0 (da)
PT (1)	PT1315518E (da)
WO (1)	WO2002020045A2 (da)
ZA (1)	ZA200301759B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7928264B2 (en) *	2004-09-21	2011-04-19	Astellas Pharma Inc.	Aminoalcohol derivatives
CN101522213A (zh)	2006-09-01	2009-09-02	Csl有限公司	引起或诱导免疫应答的方法
WO2009021291A1 (en) *	2007-08-16	2009-02-19	The University Of Sydney	Mycobacterium vaccine formulation
NZ583377A (en)	2007-10-12	2013-11-29	Csl Ltd	Method of eliciting an immune response against pandemic influenza virus
GB0910591D0 (en)	2009-06-19	2009-07-29	Immunobiology Ltd	Method for the purification of protein complexes
GB0916557D0 (en)	2009-09-21	2009-10-28	Health Prot Agency	Commensal neisserial stress protein complexes
GB201104897D0 (en)	2011-03-23	2011-05-04	Immunobiology Ltd	Method for the production of protein complexes and vaccine compositions comprising the same
MX2013012165A (es) *	2011-04-20	2014-06-11	Mico Bio Inc	Composicion y metodo para mejorar una respuesta inmune.

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3020226B2 (ja) *	1986-08-18	2000-03-15	ブリティッシュ・テクノロジー・グループ・リミテッド	ワクチン
US5776724A (en) *	1988-10-24	1998-07-07	Yale University	Chaperonin-mediated protein folding
JPH03204820A (ja) *	1989-10-12	1991-09-06	Nippon Saibai Suisan Kk	エビ類の細菌性疾病予防ワクチン及びその製造法
WO1995014093A1 (en) *	1993-05-19	1995-05-26	Institut Pasteur	Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
US6258359B1 (en) *	1993-05-19	2001-07-10	Institut Pasteur	Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
JPH0748398A (ja) *	1993-08-03	1995-02-21	Nippon Oil Co Ltd	変性蛋白質の再生方法及び変性蛋白質再生剤
US6872542B1 (en) *	1993-11-18	2005-03-29	Siga Pharmaceuticals, Inc.	Treatment or prophylaxis of diseases caused by pilus-forming bacteria
US6420127B1 (en) *	1994-11-18	2002-07-16	Washington University	Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
US5961979A (en) *	1994-03-16	1999-10-05	Mount Sinai School Of Medicine Of The City University Of New York	Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
CZ394297A3 (cs) *	1995-06-07	1998-04-15	Biochem Vaccines Inc.	Streptokokové proteiny teplotního šoku ze skupiny HSP70
US5935576A (en) *	1995-09-13	1999-08-10	Fordham University	Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US7022328B1 (en) *	1995-11-30	2006-04-04	Australian Pork Limited	Therapeutic and diagnostic compositions
IN183280B (da) *	1996-09-20	1999-10-30	Univ New Mexico
US5747332A (en) *	1996-09-20	1998-05-05	University Of New Mexico	Methods for purifying and synthesizing heat shock protein complexes
US6331388B1 (en) *	1997-10-17	2001-12-18	Wisconsin Alumni Research Foundation	Immune response enhancer
US5948646A (en) *	1997-12-11	1999-09-07	Fordham University	Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
US6500434B1 (en) *	1998-04-23	2002-12-31	Medimmune, Inc.	Chaperone and adhesin proteins; vaccines, diagnostics and method for treating infections
US6248329B1 (en) *	1998-06-01	2001-06-19	Ramaswamy Chandrashekar	Parasitic helminth cuticlin nucleic acid molecules and uses thereof
NZ509127A (en) *	1998-06-19	2004-01-30	Merieux Oravax	Use of LT (E. coli) and CT (cholera toxin) for inducing immune responses against helicobacter infection
GB9818133D0 (en) *	1998-08-19	1998-10-14	Quadrant Holdings Cambridge	Vaccine
CA2363146A1 (en) *	1999-02-22	2000-08-31	Solomon Langermann	Caulobacter lps immunoadjuvant
US7041465B1 (en) *	1999-08-11	2006-05-09	Washington University	Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof
GB9919734D0 (en) *	1999-08-19	1999-10-20	Colaco Camilo	Vaccines from infectious agents
US6677139B1 (en) *	1999-12-23	2004-01-13	Genecor International, Inc.	Methods for production of proteins in host cells
GB0004547D0 (en) *	2000-02-23	2000-04-19	Immunobiology Ltd	Screening method for novel vaccine candidates and compositions obtained thereby
WO2001078772A1 (en) *	2000-04-17	2001-10-25	Mojave Therapeutics Inc.	Heat shock protein-based antiviral vaccines
CN1107681C (zh) *	2000-08-11	2003-05-07	中国科学院微生物研究所	乙肝病毒抗原多肽与热休克蛋白的复合物及其应用
US6932985B2 (en) *	2000-10-10	2005-08-23	Auburn University	Azide method and composition for controlling deleterious organisms
WO2002059156A2 (en) *	2000-12-22	2002-08-01	Medimmune, Inc.	Therapeutic compounds structurally-linked to bacterial polypeptides
WO2003068941A2 (en) *	2002-02-13	2003-08-21	Duke University	Modulation of immune response by non-peptide binding stress response polypeptides
US8088569B2 (en) *	2002-03-01	2012-01-03	Applied Immune Technologies	Immunogens for treatment of neoplastic and infectious disease
EP1539223A2 (en) *	2002-05-02	2005-06-15	University of Connecticut Health Center	Using heat shock proteins and alpha-2-macroglobulins to increase immune response to vaccines comprising heat shock protein-peptide complexes or alpha-2-macroglobulin-peptide complexes

2000
- 2000-09-04 GB GBGB0021757.0A patent/GB0021757D0/en not_active Ceased
2001
- 2001-09-04 DK DK01963230.6T patent/DK1315518T3/da active
- 2001-09-04 EP EP01963230A patent/EP1315518B1/en not_active Expired - Lifetime
- 2001-09-04 ES ES01963230T patent/ES2337653T3/es not_active Expired - Lifetime
- 2001-09-04 DE DE60140681T patent/DE60140681D1/de not_active Expired - Lifetime
- 2001-09-04 US US10/363,454 patent/US20050232946A1/en not_active Abandoned
- 2001-09-04 WO PCT/GB2001/003964 patent/WO2002020045A2/en not_active Ceased
- 2001-09-04 AU AU2001284261A patent/AU2001284261A1/en not_active Abandoned
- 2001-09-04 IL IL15472701A patent/IL154727A0/xx unknown
- 2001-09-04 PT PT01963230T patent/PT1315518E/pt unknown
- 2001-09-04 CA CA002421229A patent/CA2421229A1/en not_active Abandoned
- 2001-09-04 JP JP2002524528A patent/JP2004508339A/ja active Pending
- 2001-09-04 AT AT01963230T patent/ATE450270T1/de active
- 2001-09-04 CN CN01815133A patent/CN1452495A/zh active Pending
2003
- 2003-03-03 ZA ZA200301759A patent/ZA200301759B/en unknown

Also Published As

Publication number	Publication date
AU2001284261A1 (en)	2002-03-22
ATE450270T1 (de)	2009-12-15
CA2421229A1 (en)	2002-03-14
IL154727A0 (en)	2003-10-31
JP2004508339A (ja)	2004-03-18
GB0021757D0 (en)	2000-10-18
ES2337653T3 (es)	2010-04-28
WO2002020045A3 (en)	2002-10-31
US20050232946A1 (en)	2005-10-20
DE60140681D1 (de)	2010-01-14
CN1452495A (zh)	2003-10-29
EP1315518A2 (en)	2003-06-04
PT1315518E (pt)	2010-03-05
WO2002020045A2 (en)	2002-03-14
ZA200301759B (en)	2004-06-22
EP1315518B1 (en)	2009-12-02

Publication	Publication Date	Title
WO2004030608A3 (en)	2005-03-10	Nanoemulsion vaccines
ES2181306T3 (es)	2003-02-16	Vacunas recombinantes que comprenden bacterias atenuadas inmunogenicas que tienen fenotipo rpos positivo.
DE602004028029D1 (en)	2010-08-19	Rwendung
DK1315518T3 (da)	2010-04-19	Vaccine mod mikrobielle patogener
ES2070266T3 (es)	1995-06-01	Vacuna contra la infeccion por escherichia coli.
NO20075727L (no)	2008-02-15	Vaksineblanding omfattende B-subenhet av et E.coli varmetoksin og et antigen og en adjuvans
DE60336927D1 (da)	2011-06-09
WO2001063278A3 (en)	2002-03-14	Antigenic fragments associated with stress-induced proteins and their use as vaccines
AR020084A1 (es)	2002-04-10	Pestivirus atenuados
ATE542544T1 (de)	2012-02-15	Pro-apoptotische bakterielle impfstoffe zur verbesserung der zellulären immunantwort
CY1105947T1 (el)	2011-04-06	Νουκλεϊνικα οξεα και πρωτεϊνες του γονιδιου mhp3 του mycoplasma hyopneumoniae και χρησεις αυτων
DK1334197T3 (da)	2011-04-04	Gær-afledt vaccine mod IPNV
WO2005012538A3 (en)	2006-01-26	Accelerated vaccination
DK1204422T3 (da)	2010-03-15	Stress-proteiner fra extra-cellulære patogener som vacciner mod sygdomsfremkaldende organismer
NO20062469L (no)	2006-06-30	Streptococcus phocae vaksine
ATE353226T1 (de)	2007-02-15	Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
CA2366056A1 (en)	2000-09-14	Non-spreading pestivirus
PT1370668E (pt)	2006-06-30	Vacinas de vector baseadas em leporipox
AU1853995A (en)	1995-09-25	Vaccine compositions
CU23358B7 (es)	2009-03-16	Vacuna que comprende una proteína cemento de garrapata
ATE413887T1 (de)	2008-11-15	Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene
WO2006037383A8 (en)	2007-12-21	Piscirickettsia salmonis antigens and use thereof
MXPA03010910A (es)	2004-11-22	Metodo para generar microorganismos no virulentos a partir de patogenicos, mediante modificacion genetica permanente de su membrana bioligica, para producir vacunas.
HK1075842A (en)	2005-12-30	Nanoemulsion vaccines
CU22986A1 (es)	2004-09-09	Uso de las proteínas cry de bacillus thuringiensis como agentes inmunoestimuladores y vectores para la presentación de epitopes vacunales